Literature DB >> 2112615

T-cell-induced expression of human immunodeficiency virus in macrophages.

R D Schrier1, J A McCutchan, J C Venable, J A Nelson, C A Wiley.   

Abstract

Macrophages are major reservoirs of human immunodeficiency virus (HIV) in the tissues of infected humans. As monocytes in the peripheral blood do not show high levels of infection, we have investigated the expression of HIV in T-cell-activated, differentiated macrophages. Peripheral blood mononuclear cells were isolated from HIV-seropositive individuals and stimulated with antigens or mitogens, and the nonadherent fraction was removed. Macrophages were cultured alone for 2 weeks, and HIV expression was assessed. Results from p24 antigen capture assays demonstrated that the presence of autologous T cells and concanavalin A or autologous T cells and allogeneic cells for the initial 24 h of culture induced HIV expression in 35 of 47 (74%) HIV-seropositive patients tested. The macrophage monolayers could be immunostained with anti-HIV antibodies to reveal discrete infectious centers, indicating that complete virus replication was occurring in the macrophages and that infection of adjacent cells was mediated by cell-cell contact. Time course studies of the interval of coculture of the adherent and nonadherent cells indicated that 24 h (but not 2 h) was sufficient for induction of HIV in the macrophages. Direct contact between the adherent cells and activated T cells was required as well. Since the presence of autologous T cells also appeared to be necessary, induction of HIV expression in macrophages may be genetically restricted. HIV-seronegative nonadherent cells were able to induce HIV expression in macrophages from HIV-seropositive donors, demonstrating that the virus originated in the monocytes and was reactivated in the context of a classic T-cell-mediated immune reaction. The high percentage of monocytes from HIV-seropositive donors which can be induced to replicate HIV by activated T cells suggests that infection of monocytes may be critical to the pathogenesis of this lentivirus infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112615      PMCID: PMC249555     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.

Authors:  G Poli; B Bottazzi; R Acero; L Bersani; V Rossi; M Introna; A Lazzarin; M Galli; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

2.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).

Authors:  J K Nicholson; G D Cross; C S Callaway; J S McDougal
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

Review 3.  The interleukins.

Authors:  S B Mizel
Journal:  FASEB J       Date:  1989-10       Impact factor: 5.191

4.  HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.

Authors:  K Tenner-Racz; P Racz; M Bofill; A Schulz-Meyer; M Dietrich; P Kern; J Weber; A J Pinching; F Veronese-Dimarzo; M Popovic
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

5.  Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro.

Authors:  M S Hirsch; S M Phillips; C Solnik; P H Black; R S Schwartz; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

6.  Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

Authors:  D D Ho; T R Rota; R T Schooley; J C Kaplan; J D Allan; J E Groopman; L Resnick; D Felsenstein; C A Andrews; M S Hirsch
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

7.  Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.

Authors:  P D Smith; K Ohura; H Masur; H C Lane; A S Fauci; S M Wahl
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

8.  Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types.

Authors:  R Collman; N F Hassan; R Walker; B Godfrey; J Cutilli; J C Hastings; H Friedman; S D Douglas; N Nathanson
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

9.  Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.

Authors:  L B Olding; F C Jensen; M B Oldstone
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  21 in total

1.  In vitro activation of feline immunodeficiency virus in ramified microglial cells from asymptomatically infected cats.

Authors:  A Hein; J P Martin; R Dörries
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo.

Authors:  J A Mikovits; N C Lohrey; R Schulof; J Courtless; F W Ruscetti
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  R D Schrier; C A Wiley; C Spina; J A McCutchan; I Grant
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Exosomes from uninfected cells activate transcription of latent HIV-1.

Authors:  Robert A Barclay; Angela Schwab; Catherine DeMarino; Yao Akpamagbo; Benjamin Lepene; Seble Kassaye; Sergey Iordanskiy; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

5.  The inability of human immunodeficiency virus to infect chimpanzee monocytes can be overcome by serial viral passage in vivo.

Authors:  H E Gendelman; G D Ehrlich; L M Baca; S Conley; J Ribas; D C Kalter; M S Meltzer; B J Poiesz; P Nara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.

Authors:  B Chesebro; J Nishio; S Perryman; A Cann; W O'Brien; I S Chen; K Wehrly
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Human cytomegalovirus productively infects primary differentiated macrophages.

Authors:  C E Ibanez; R Schrier; P Ghazal; C Wiley; J A Nelson
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.

Authors:  B Chesebro; K Wehrly; J Nishio; S Perryman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.